OCT - 3 2003 §10(k) Summary
General Information 4 032702 Cea lof ")
Classification Class JI
Trade Name VivaTip™ Microwave Ablation Probe and Accessories
Submitter Vivant Medical, Inc.
1916-A Old Middlefield Way
Mountain View, CA 94043
(650) 694-2900
Contact Steven Kim
Vice President of Research and Development
Intended Use
The VivaTip™ Microwave Ablation Probe is intended for coagulation of soft tissue. Not for use in
cardiac procedures.
Predicate Devices
VivaWave™ Microwave Ablation System K011676
Tri-Loop™ Microwave Ablation Probe K032047
Device Description
The VivaTip™ Microwave Ablation Probe is a needle-like device that is inserted into soft tissue
and coagulates a volume of tissue surrounding the active area of the probe. The probe is to be
used with the VivaWave™ microwave power generator. Accessories to assist in cooling the shaft
of the probe and to hold multiple probes together for simultaneous ablation are included.
Materials
All patient contact materials used in the manufacture of the VivaTip™ Microwave Ablation
Probe are suitable for this use and have been used in numerous previously cleared products.
Summary of Substantial Equivalence
The VivaTip™ Microwave Ablation Probe is equivalent to the predicate products. The
indications for use, basic overall function, methods of manufacturing, and materials used are
substantially equivalent. Vivant Medical believes the VivaTip™ Microwave Ablation Probe is
substantially equivalent to existing legally marketed devices.
Confidential 1s

oe,
é M4 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
te, TTT
nanan Food and Drug Administration
9200 Corporate Boulevard
OCT - 3 2003 Rockville MD. 20850

Mr. Stephen Kim
Vice President of Research and Development
Vivant Medical, Inc.
1916-A Old Middlefield Way
Mountain View, California 94043
Re: K032702

Trade/Device Name: VivaTip™ Microwave Ablation Probe and Accessories

Regulation Number: 21 CFR 878.4400

Regulation Name: Electrosurgical cutting and coagulation device and accessories

Regulatory Class: I

Product Code: GEI

Dated: August 29, 2003

Received: September 3, 2003
Dear Mr. Kim:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general contrdls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class HI (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Stephen Kim
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

fre M. Witten, Ph.D., M.D.
: Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological I fealth
Enclosure : soa

Indicatious for Use
510(k) Number Gf known): Fhis-application KO32 FORD
Device Name: VivaTip™ Microwave Ablation Probe and Accessories
Indications for Use: , The VivaTip™ Microwave Ablation Probe is intended
for coagulation of soft tissue. Not for use in cardiac
procedures.
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF
NEEDED) o
Concurtence of CDRH, Office of Device Evaluation (ODE)
Prescription Use K OR Over-The-Counter Use
(Per 21 CFR 801.109) | Le Format 1-2-96)
Division Sign-Oft} |
Division of General, Restorativ=
and Neurological Devices
03 >}0>
=19(k) Number _K039
Confidential 17

